Trimethobenzamide SUPPOSITORIES (Tigan) will go off the market

May 2007

Trimethobenzamide SUPPOSITORIES (Tigan) will go off the market...but the oral and injectable forms will stay.

Trimethobenzamide is one of those "unapproved" drugs that came on the market before proof of efficacy was required. Now the FDA is requiring efficacy data...or they'll take these drugs off the market.

There's just not enough evidence the SUPPOSITORIES are effective.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote